Related Experiment Video
Updated: Oct 25, 2025
06:11
Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
10.0K
Head and neck cancer: Current challenges and future perspectives.
Gh Rasool Bhat1, Rosalie G Hyole1, Jiong Li2
1Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, United States.
Advances in Cancer Research
|August 6, 2021
Summary
Head and neck squamous cell carcinomas (HNSCC) are aggressive cancers with poor survival rates. Research focuses on understanding HNSCC biology to find biomarkers for better targeted therapies.
Area of Science:
- Oncology and Molecular Biology: Investigating the complexities of head and neck cancers.
Background:
- Head and neck cancers (HNSCC) are a diverse group of aggressive malignancies.
- Approximately 90% of HNSCC are squamous cell carcinomas, often linked to tobacco, alcohol, or human papillomavirus (HPV).
- Current treatments like surgery and radiotherapy have limitations, including significant morbidity and resistance, leading to poor patient prognosis.
Purpose of the Study:
- To understand the molecular pathogenesis of HNSCC.
- To identify predictive and prognostic biomarkers for improved treatment strategies.
- To develop more effective, less toxic, and highly specific targeted therapies for HNSCC.
Main Methods:
- Elucidation of the genetic landscape of HNSCC.
- Analysis of the tumor microenvironment in HNSCC.
- Investigation of aberrant signaling pathways in HNSCC.
Main Results:
- Insights into the molecular pathogenesis of HNSCC.
- Identification of key biological and immunobiological factors.
- Understanding of factors contributing to treatment resistance and relapse.
Conclusions:
- Further understanding of HNSCC biology and immunobiology is crucial.
- Biomarker identification is key to developing targeted therapies.
- Future research aims for more effective and less toxic treatments with high specificity for HNSCC patients.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
8.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.0K
01:30Cancer Vaccines
581
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
581
01:21Cancer Survival Analysis
481
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
481
02:49Cancer Therapies
8.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.8K
02:56Treatment Resistant Cancers
3.5K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
02:18Cancer
51.0K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.0K